ViroPharma beats Street

ViroPharma Inc. (NASDAQ:VPHM) reported 2Q10 diluted GAAP EPS of

Read the full 93 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE